Application and effect of aerobic exercise of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease
10.3760/cma.j.issn.1673-4904.2013.13.002
- VernacularTitle:有氧运动肺康复治疗在慢性阻塞性肺疾病患者中的应用及效果研究
- Author:
Yunhui CHEN
;
Hongquan WEI
;
Yinhui LIU
;
Lixian ZHENG
;
Wei LUO
;
Bowen ZENG
;
Ziyu CHEN
- Publication Type:Journal Article
- Keywords:
Pulmonary disease,chronic obstructive;
Treatment outcome;
Aerobic exercise;
Pulmonary rehabilitation
- From:
Chinese Journal of Postgraduates of Medicine
2013;(13):5-8
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the application and effect of aerobic exercise of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD).Methods Ninety-four hospitalized patients with COPD from June 2011 to June 2012 were enrolled.The clinical curative effect and safety of aerobic exercise of pulmonary rehabilitation in patients with COPD were observed and compared.Results After 3 months treatment,first second forced expiratory volume (FEV1) and forced vital capacity (FVC) were increased compared with those before treatment [(3.25 ± 0.49) L vs.(2.59 ± 0.55) L,(1.95 ± 0.41) L vs.(1.44 ± 0.48) L],and there were significant differences (P ＜ 0.05).There was no significant difference in FEV1/FVC before and after treatment (P ＞ 0.05).After 3 months treatment,arterial partial pressure of oxygen and arterial oxygen saturation were increased compared with those before treatment [(87.61 ± 8.56) mm Hg(1 mm Hg =0.133 kPa) vs.(63.88 ± 8.79) mm Hg,0.9648 ±0.0449 vs.0.7632 ± 0.0477],partial pressure of arterial carbon dioxide was decreased compared with that before treatment [(30.57 ± 9.47) mm Hg vs.(49.23 ± 9.54) mm Hg],and there were significant differences (P ＜ 0.05).There was no signifi.cant difference in blood pressure and heart rate before and after treatment (P＞ 0.05).No obvious adverse reactions were observed.Conclusions The aerobic exercise of pulmonary rehabilitation can improve significantly lung function.It is safe and rehable,and has less adverse reaction in patients with COPD.It is worthy of promotion and use.
